 |
|
|
| |
12-month outcomes - patient satisfaction - of Dolutegravir (DTG) + Lamivudine (3TC) in ART-naïve and pre-treated PLHIV in Germany: Real-world data from the German URBAN cohort
|
| |
| |
EACS 2021 Oct 27-30
Stefan Scholten1, Sebastian Noe2, Christoph Wyen3, Daniel Beer4, Nils Postel5, Olaf Degen6, Ramona Pauli7, Heribert Hillenbrand8, Bernd Westermayer9, Kathrin M Dymek10, Jenny Scherzer10
1Praxis Hohenstaufenring, Cologne, Germany; 2MVZ München am Goetheplatz, Munich, Germany; 3Praxis Ebertplatz, Cologne, Germany; 4Praxis Dr. Knechten Aachen, Germany; 5prinzmed, Munich, Germany; 6Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 7Isarpraxis Munich, Germany; 8MVZ PraxisCityOst, Berlin, Germany; 9GlaxoSmithKline, Munich, Germany; 10ViiV Healthcare, Munich, Germany
|
| |
|
|
|
|
|
